Showing results (511-520 of 605) with videos related to

Sort By:
Pageof 61
Frontiers in Molecular Neuroscience|January 30, 2018
Disturbed Processing of Contextual Information in HCN3 Channel Deficient MiceMarc S Stieglitz, Stefanie Fenske, Verena Hammelmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 13, 2021
Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effectSheriene Moussa Afify, Andreas Regner, Luis F Pacios, et al.
Nature Reviews. Neurology|April 24, 2020
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disordersNicholas J Ashton, Abdul Hye, Anto P Rajkumar, et al.
Alzheimer'S Research & Therapy|May 25, 2023
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [18F]flortaucipir studyAntoinette O'Connor, David M Cash, Teresa Poole, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2025
[18F]SiTATE PET for PRRT selection and monitoring metastatic tumors of the adrenal medulla and extra-adrenal paragangliaSophie C Siegmund, Adrien Holzgreve, Magdalena Schöll, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2021
[Air and maritime transport during the COVID-19 pandemic in Germany: challenges for the public health service]Scarlett Kleine-Kampmann, Meike Schöll, Lena Ehlers, et al.
Science Translational Medicine|January 22, 2025
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer's diseaseSebastian N Roemer-Cassiano, Fabian Wagner, Lisa Evangelista, et al.
Research Square|October 27, 2023
Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measureRobel K Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's diseaseSandar Aye, Gunilla Johansson, Christoph Hock, et al.
Pageof 61